Authors: Sherman, DG Bes, A Easton, JD Hacke, W Kaste, M Polmar, SH Zivin, JA Fieschi, C Miller, P Schoenfeld, D Street, J Albers, G Atkinson, R Biller, J Bruno, A Carpenter, D Clark, W DeGraba, T Driscoll, P Ellis, J Greenlee, R Hess, D Horowitz, DR Davenport, J Hsu, C Starkman, S Madden, K Pettigrew, C Rosenbaum, D Schim, J Tietjen, G Mansbach, H Edwards, K Webb, R Crisostomo, E Wilterdink, J Rothrock, J Zweifler, R Dexter, J Horowitz, S Futrell, N Alter, M Schneider, D Ferbert, A Hacke, W Prange, H Wiersbitzky, M Buttner, T Schwartz, A Busse, O Klingelhofer, J Kaste, M Erila, T Sivenius, J Sotaniemi, K Liukkonen, J Hedman, C Muuronen, A Rissanen, A Bes, A Feve, JR Mahagne, MH Rancurel, G Trouillas, P Weber, M Thomassen, L Johnsen, HJ Kjallman, L Petersson, J Ferrari, G Lagi, A Mamoli, A Re, G

Citation: Dg. Sherman et al., Use of anti-ICAM-1 therapy in ischemic stroke - Results of the Enlimomab Acute Stroke Trial, NEUROLOGY, 57(8), 2001, pp. 1428-1434

Authors: Levine, SR Brott, T Broderick, J Kothari, R O'Donoghue, M Barsan, W Tomsick, T Spilker, J Miller, R Sauerbeck, L Farrell, J Kelly, J Perkins, T Hospital, MU McDonald, T Rorick, M Hickey, C Armitage, J Perry, C Thalinger, K Rhude, R Schill, J Becker, PS Heath, RS Adams, D Reed, R Klei, M Hughes, A Anthony, J Baudendistel, D Zadicoff, C Rymer, M Bettinger, I Laubinger, P Schmerler, M Lyden, P Dunford, J Zivin, J Rapp, K Babcock, T Daum, P Persona, D Brody, M Jackson, C Lewis, S Liss, J Mahdavi, Z Rothrock, J Tom, T Zweifler, R Kobayashi, R Kunin, J Licht, J Rowen, R Stein, D Grisolia, J Martin, F Chaplin, E Kaplitz, N Nelson, J Neuron, A Silver, D Chippendale, T Diamond, E Lobatz, M Murphy, D Rosenberg, D Ruel, T Sadoff, M Schim, J Schleirner, J Atkinson, R Wentworth, D Cummings, R Frink, R Heublein, P Grotta, JC DeGraba, T Fisher, M Ramirez, A Hanson, S Morgenstern, L Sills, C Pasteur, W Yatsu, F Andrews, K Villar-Cordova, C Pepe, P Bratina, P Greenberg, L Rozek, S Simmons, K Kwaitkowski, TG Horowitz, SH Libman, R Kanner, R Silverman, R LaMantia, J Mealie, C Duarte, R Donnarumma, R Okola, M Cullin, V Mitchell, E Levine, SR Lewandowski, CA Tokarski, G Ramadan, NM Mitsias, P Gorman, M Zarowitz, B Kokkinos, J Dayno, J Verro, P Gymnopoulos, C Dafer, R D'Olhaberriague, L Sawaya, K Daley, S Mitchell, M Frankel, M Mackey, B Weissman, J Washington, J Nguyen, B Cook, A Karp, H Williams, M Williamson, T Barch, C Braimah, J Faherty, B MacDonald, J Sailor, S Kozinn, M Hellwick, L Haley, EC Bleck, TP Cail, WS Lindbeck, GH Granner, MA Wolf, SS Gwynn, MW Mellelal, RW Chang, CWJ Solenski, NJ Brock, DG Ford, GF Kongable, GL Parks, KN Wilkinson, SS Davis, MK Sheppard, GL Zontine, DW Gustin, KH Crowe, MN Massey, SL Meyer, M Gaines, K Payne, A Bales, C Malcolm, J Barlow, R Wilson, M Cape, C Bertorini, T Misulis, K Paulsen, W Shepard, D Tilley, BC Welch, KMA Fagan, SC Lu, M Patel, S Masha, E Verter, J Boura, J Main, J Gordon, L Maddy, N Chociemski, T Windham, J Zadeh, HS Alves, W Keller, MF Wenzel, JR Raman, N Cantwell, L Warren, A Smith, K Bailey, E Welch, KMA Froehlich, J Breed, J Easton, JD Hallenbeck, JF Lan, G Marsh, JD Walker, MD Marler, JR

Citation: Sr. Levine et al., Effect of intravenous recombinant tissue plasminogen activator on ischemicstroke lesion size measured by computed tomography, STROKE, 31(12), 2000, pp. 2912-2919